Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
To assess in children the efficacy and safety of 2 dosing regimens of T1225 1.5% eye drops,
in comparison to a reference product, single-dose oral azithromycin (AZM) 20 mg/kg, for the
treatment of active trachoma. Evaluation of clinical efficacy was primary (% of clinical cure
at Day 60 in Per Protocol Set), microbiological evaluation was secondary